PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31315136-5	2019	ALP reduction was greatest for vancomycin (65.6%, p < 0.002) and smallest with metronidazole (22.7%, p = 0.18).	Metronidazole	79-92	alkaline phosphatase, placental	Homo sapiens	0-3	
15565569-7	2004	After 36 months, serum aminotransferases gamma-glutamyltransferase, and alkaline phosphatase (ALP) decreased markedly in both groups, serum ALP more significantly in the UDCA/MTZ group (-337 +/- 54 U/L, P &lt; .05) compared with the UDCA/placebo group.	Metronidazole	175-178	alkaline phosphatase, placental	Homo sapiens	140-143	
26378046-11	2015	Additionally, UDCA plus MTZ (MD -544.66, P &lt; 0.001) showed a significant reduction in ALP levels compared with OBS, but appeared to be associated with more AEs compared with UDCA (OR 5.09), UDCA plus MMF (OR 4.80) or OBS (OR 7.21).	Metronidazole	24-27	alkaline phosphatase, placental	Homo sapiens	89-92	
15565569-11	2004	In conclusion, combining MTZ with UDCA in PSC improved serum ALP levels and New Mayo Risk Score, but no statistically significant effect on disease progression as assessed via liver histology or ERCP was seen.	Metronidazole	25-28	alkaline phosphatase, placental	Homo sapiens	61-64